hotspot -WSS

hotspot

author：focus 2025-10-01 23:00:50 - browse：57

AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it was spun off from the device maker Abbott Laboratories in 2013, will step down in July. Gonzalez had previously said he would depart when AbbVie had a plan in place to move on from its best-selling drug, Humira, which is now facing competition from cheaper biosimilars.

He will be replaced by Chief Operating Officer Robert Michael, who, like Gonzalez, is a longtime AbbVie executive. Gonzalez, 70, will become executive chairman of the board of directors.

Gonzalez should be a sobering reminder to the drug industry’s critics of how resilient a CEO’s reputation can be. Because while he has been a subject of nearly constant criticism for AbbVie’s handling of Humira and the patents protecting it, investors are likely to remember him fondly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Readout LOUD podcast, live from the STAT Breakthrough Summit East

WSS

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Adam's Take: Intra

When a patient nears the end, a feared therapy can comfort

Caribou posts encouraging results on off

Surgeons perform first xenotransplant using CRISPR'd pig kidney

focus

hotspot

knowledge

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: Illumina, CRISPR, Regeneron

Guidelines to prevent youth baseball injuries need more muscle

After a decade, new Gardasil ad campaign gets it (mostly) right

How to save PrEP access — and even expand it

Extensive review finds private equity owners jack up cost of care

Walensky prepares to leave CDC — and Congress — behind

This gene therapy has record $4.25 million price. It's saved children.

Medical leaders decry Supreme Court decision on affirmative action

Erich Jarvis studies song birds to learn about human stuttering

focus

Readout LOUD podcast, live from the STAT Breakthrough Summit East

This gene therapy has record $4.25 million price. It's saved children.

Are infertility treatments 'essential' during the Covid

Asbestos ban is immediate, but health effects will linger for decades

Biotech investment managers search for lucrative opportunities

Yancopoulos of Regeneron works to expand Dupixent success

focus

focus

leisure time

entertainment